基础研究:Effects of Combination Therapy with Levamlodipine and Bisoprolol on Stroke in Rats

合集下载

氯吡格雷抵抗相关因素的研究进展

氯吡格雷抵抗相关因素的研究进展

A.Wisozo∞k
with
daily dose of 150
or
75
phnsphnrylatien
for the detection of ciopidogrel
mg of clopidogmlfor 30
days[J].EurHeart
with
J,2007,28:1814・1819.

ischemic cardiovascular
clopldogrol resistance.
Key words:clopidogrel;clopidogrel resistance;platelet aggregation
・通讯作者:陈玉国,山东大学齐鲁医院急诊科,教授,博士生导师,研究方向:急性冠脉综合征的基础和临床研究,E-mail:chen919085@126.corn
Q池Hospital旷Shandong
University,五砌250012,China)
中图分类号:R973+.2 文献标识码:A
文章编号:1004-3934(2009)06-0991-04
摘要:
ll鑫床上部分冠状动脉性心脏病患者未从氯吡格雷抗血小板治疗中获益,这就是氯吡格雷抵抗现象。氯吡格雷抵抗反
activity[J].Scmin
CD,Wiviott
o[1
[25】
Brandt
dogrel hted
JT,Payne
and
clopi・
re-
meUi船[J】.Anerloeder
Thromb Vasc Bid,2006,26
loading doses
to
platter function:magnitude of platelet

二肽基肽酶Ⅳ抑制剂的作用机制与临床应用

二肽基肽酶Ⅳ抑制剂的作用机制与临床应用

二肽基肽酶Ⅳ抑制剂的作用机制与临床应用发布时间:2021-07-22T16:01:57.060Z 来源:《医师在线》2021年16期作者:张巧利通讯作者:刘霞[导读] 临床研究[1]显示,DPP-Ⅳ抑制剂对于 2 型糖尿病患者有着良好的降血糖效果,而且这一作用具有葡萄糖依赖性,因此引起低血糖事件发生的频率很低。

张巧利通讯作者:刘霞重庆市沙坪坝区人民医院?全科医学科重庆市 400000 二肽基肽酶Ⅳ(Dipeptidyl peptidase-Ⅳ, DPP-Ⅳ)抑制剂是一种较新的口服降糖药物。

临床研究[1]显示,DPP-Ⅳ抑制剂对于 2 型糖尿病患者有着良好的降血糖效果,而且这一作用具有葡萄糖依赖性,因此引起低血糖事件发生的频率很低。

同时其在与2型糖尿病发生、发展相关的病理、生理学方面可产生对人体有益的作用,尤其是在改善胰岛 β 细胞功能方面有着值得关注的潜能。

近年来,有更多的相关临床研究,可以更全面的认识DPP-Ⅳ抑制剂。

本文关注于DPP-Ⅳ抑制剂产生降糖作用的生物学机制,作用效果及使用的安全性作如下综述。

1 作用机制DPP-Ⅳ抑制剂主要通过抑制二肽基肽酶Ⅳ,延缓酶对内源性胰高血糖素肽-1(Glucagon like peptide-1, GLP-1)的降解,提高其浓度,延长其生物活性,以发挥降糖作用。

1.1 GLP-1的生物学效应 GLP-1是由肠L细胞产生的促胰岛素分泌肽,参与肠促胰岛素效应,膳食引起的高血糖促进肠GLP-1分泌,胰岛β细胞在此激素的刺激下胰岛素分泌增多。

1.1.1 GLP-1可促进胰岛素的分泌、合成 GLP-1参与葡萄糖依赖性的促进胰岛素分泌的效应,这一效应的强弱与血糖浓度呈正相关,随着血糖的增高,效应越强;反之,效应减弱。

当血糖下降至3.36mmol/L时,GLP-1刺激胰岛素分泌的作用甚至会消失。

因此,DPP-Ⅳ抑制剂,通过GLP-1降糖,可避免严重低血糖的发生。

GLP-1对于胰岛素的作用,不仅可增加其释放,还能促进其生物合成。

急性冠脉综合征合并高血糖的研究进展

急性冠脉综合征合并高血糖的研究进展

中日友好医院学报2010年第24卷第2期JbⅢ矗矿劬iM—J印∞胁,珧^咖Ⅳ唧n吐2D,D^Jpr'y。

f.2tⅣ0.2111急性冠脉综合征合并高血糖的研究进展周颖,周益峰,王勇(中日友好医院心内科,北京100029)中图分类号:R541.4文献标识码:A文章编号:1001-0025(2010)02-01ll一03doi:10.3969/j.issn.1001--0025.2010.02.015急性冠脉综合征(acutecoronary8yndrome.ACS)患者常合并有高血糖。

流行病学资料显示.ACS患者人院时高血糖的发生率为25%~50%.甚至更高。

目前最大的关于高血糖和ACS的回顾性研究联合心血管计划(cooperativecardiovascularproject.CCP)研究显示.高血糖是ACS患者常见的并存情况.50%以上确诊ACS的患者入院时伴血糖升高…。

高ff【【糖增加ACS患者住院期间的并发症发生率.影响其预后和存活率。

对心血管医生而言.ACS合并高血糖患者的治疗除了针对ACS的策略之外.血糖异常的处理也应当引起足够的重视。

1ACS合并高血糖与预后的关系1.1ACS患者入院时高血糖与预后临床研究证实.入院高血糖是ACS患者预后不良的重要凶素。

CCP研究中.入院时血糖>110mg/dl的ACS患者.其30d死亡率较对照组增加13%.77%.而1年死亡率增加7%。

46%ol。

这部分患者中,既往未诊断糖尿病者30d死亡率高于已诊断糖尿病者。

Bhadriraju观察了OPUS—TIMI16研究中9020例ACS患者入院时血糖与长期死亡率的关系.发现高血糖者脑钠肽和肌钙蛋白水平也较高,高血糖与lO个月时的死产率明显相关.结论:高血糖是ACS患者长期死亡率的独立预测因子.并且与预测预后的生物因子水平升高有关[21。

此外.Rocha等的研究也表明入院高血糖为非糖尿病ACS患者的死亡率预测冈子|3J。

医学论文英文摘要写作技巧

医学论文英文摘要写作技巧

医学论文(medical papers)的定义医学论文是对整理和发表医学研究成果的一种特殊文本的总称,就其内容和文体特点而言科分为以下几种:1.医学科研论文(scientific papers)2.调查报告(survey)3.综述(review)4.学位论文(theses)5.医学科研论文(scientific papers)医学科研论文定义国际生物学编辑委员会对医学科研论文的定义为:必须是首次公布的应提供足够的资料,使同行们能够进行:①评价所观察到的结果;②评价其推理过程;③重复实验。

分为以下两种:①临床研究(clinical study);②基础研究或实验研究(experimental study)医学科研论文的格式医学科研论文必须具备以下几个部分:(1)标题(title)(2)摘要(abstract)(3)引言(introduction)(4)材料和方法(materials and methods)(5)结果(results)(6)讨论(discussion)(7)致谢(acknowledgement)(8)参考文献(references)一、标题(一)要求1.简明扼要(short and concise)(1)尽量控制在一行,但不是一个句子(2)不超过25 个单词或120-140 个字母(3)除DNA、RNA、CT 等不用缩写2.信息丰富(informative)3.便于索引(indexing)4.较长标题可采用副标题(二)标题写作中常用词组和表达方式1.用…(方法/手段)对…进行研究/分析/观察/评价:Study(analy sis/observation/evaluation/assessment) of (on) … (by) using 方法/with 工具)2.A 对B 的作用Effort of A on BProtective effect of omeprazole on endothelin-induced gastric mucosal injury3.A 与B 的关系Correlation (relation/relationship) between A and BCorrelation of A with B and C常用修饰词:positively/negatively/significantly/insignificantly4.用…治疗…Use of …in the treatment of …( 病)in …(生物)Use of omeprazole in the treatment of gastric ulcer in the elderly5.A 是BA as B二、著录部分书写(一)姓名标准式:WANG Luowei,HUANG Yingfeng,GUO Xiao’an(二)地址800 Xiang Yin Road, Shanghai 200433, P.R.China(三)资助A project funded by the National “863” Program三、摘要的分类与格式摘要是作者要给读者的精华,分两大类:(一)指示性摘要(二)资料性摘要1.非结构式摘要缺点:段落不明,给编辑、审稿、阅读和计算机处理带来诸多不便2.全结构式摘要(8 要素摘要)(1)目的(2)设计(3)地点(4)对象(5)处理(6)主要测定项目(7)结果(8)结论全结构式摘要的优点(1)观点更明确(2)信息量更大(3)差错更少(4)符合计算机数据库建立和使用的要求全结构式摘要的缺点:烦琐、重复、篇幅过长3.半结构式摘要(四要素摘要)(1)目的(objective/purpose/aim)(2)方法(methods)(3)结果(results)(4)结论(conclusion)目的:是作者想要介绍的关键问题一、目的格式(一)单表目的(二)背景+目的二、目的常用时态(一)背景:现在时(一般现在时、完成时和进行时)(二)目的:一般现在时/现在完成时,或一般过去时举例:(1)To evaluate the effects on 24-hour intragastric pH levels of infusions with omeprazole and H2 receptor antagonists in bleeding duodenal ulcer patients.(2)The role of omeprazole in triple therapy and the impact of Helicobacter pylori resistance on treatment outcome are not established. This study investigated the role of omeprazole and influence of primary H. pylori resistance on eradication and development of secondary resistance.三、介绍目的常用句型主要用动词不定式to 表达1.直接用to do 短语表达举例:To determine if use of omeprazole protects against the gastric mucosal injury2.The purpose/aim/objective/goal(of present study is)was to举例:The aim of this study was to determine the protective function of omeprazole on gastric mucosal injury3.The present study is /was designed/devised/intended to举例:The present study was designed to establish whether theremight be a genetic predisposition to an altered pattern of anti-inflammatory cytokine produced in patients with irritable bowel syndrome4.This study was performed/conducted/carried out/undertaken to举例:An experimental study was conducted using a canine mode to elucidate …5.We aimed/sought to/attempted to举例:We sought to assess whether there is an increased risk of tuberculosis among individuals who work in certain industries occupations.四、介绍目的常用动词1.研究:study, investigate, examine, observe, explore举例:Our objective in this report is to examine the clinical feature, pathology and treatment for patients with pancreatic cancer.2.评价:evaluate, validate举例:To evaluate sonography as a tool for initial diagnosis in emergency room patients with abdominal trauma.3.确定:determine, decide, confirm, support, define, characterize4.证实:prove, demonstrate, document, test, support, testify, verify5.阐明、搞清:explain, elucidate, clarify, illustrate, delineate, find out, contribute to the knowledge of6.介绍:describe, present, report7.建立:establish, develop, set out8.寻找:search for, look for, seek, find9.识别、区分:identify, differentiate, discriminate10.优选:optimize11.比较:compare12.回顾:review13.相关:correlate A with B方法部分(1)研究设计(2)研究对象的特性(3)干预或处理方法(4)测定或观察方法一、研究对象的选择、来源及标准1.纳入研究:were entered into/enrolled in/selected (randomly)举例:A total of 169 patients were included in the study, 83 of whom received……2.排除或退出研究:were excluded from participation,withdrew from the study due to/because to举例:……Pat ients with significant aortic valvular diseases were excluded.二、研究对象的分组1.……were divided into/classified/grouped into2.……were divided randomly/randomize d into3.…… were divided equally into举例:Patients were divided into three groups: Group 1…… Patients (n = 539) with a history of duodenal ulcer and a positive H. pylori screening test result were randomized into 4 groups. OAC group received 20 mg omeprazole, ……三、年龄1.某一年龄举例:A 50-year-old patient. Patients (age 26±3 years).2.在某年龄范围内及平均年龄举例:Patients range in age from …to…, with a mean of (50 years).3.在某一年龄以上或以下举例:Patients more than 50 years. Patients under/less than 50 years.四、性别、时间1.性别twelve patients (7 male and 5 female)The male-to-female ratio was 1:42.时间Body weight was measured weekly, and liver biopsy was obtained at 4, 8 and 12 weeks. ……五、诊断与治疗1.诊断be diagn osed as having …be diagnosed as …by …/with …?be suspected as …2.治疗be treated with…(alone or in combination with …)be treated on outpatient/inpatient basis举例:(1)Patients (n = 539) with a history of duodenal ulcer and a positive H. pylori screening test result were randomized into 4groups. OAC group received 20 mg omeprazole,…(2)50 patients with active bleeding duodenal ulcer were randomly assigned to receive one of the four treatment regimens. …结果部分1.是文章结论的根据2.应记录真实的科研数据3.除指示性说明外,一般用过去时表示一、常用句型1.结果表明:The results showed / demonstrated / revealed / documented / indicated/suggested…that…?It was found that…举例:The results showed that high thigh cuff Doppler technique was 79 percent sensitive, 56 percent specific and 63 percent accurate.2.与…有关:A was related / correlated /associated with B. There wasa relationship /correlation between A and B. There was a relation of A with B and C 举例:Insulin sensitivity index was negatively with blood velocity (r=0.530,P<0.05), body mass index (r=o.563, P<0.01) and baseline insulinemia (r=0.489, P<0.05)3.增加或减少(1)表示数值增加的动词:increase, rise, elevate(2)表示数值增加的名词:increase, increment, elevation(3)表示数值减少的动词:decrease, reduce, fall, drop, decline, lower(4)表示数值减少的名词:decrease, decrement, reduction, fall, drop, decline, lowering(5)从…增加到…,平均增加…:increase from …to …, with amean/average (increase) of …(6)从…增加到…,总的增加…:increase from …to …, with an overall increase of …(7)增加了10%:increase by (10%)4.倍数比较(1)增加或减少3 倍:increase by 3 fold (times). a 3-fold increase(2)A 是B 的3 倍:A is 3 fold (times) as…as B. A is 3 fold (times)B5.结果的统计学意义(1)明显不同(significant difference)(2)很明显不同(very/highly significant difference)(3)区别不明显(insignificant difference)(4)无区别(nonsignificant difference/no difference)6.统计学意义常用句型(1)There was/is significant difference in…between A and B(2)The difference in …between A and B was/is significant(3)A was/is significant difference from B in …(4)No significant difference was found / observed / notedin …between A and B“in” 表示区分的性质或内容举例:①There were no significant difference between treatment groups in symptoms and lung function (P>0.05).②Significant difference were not noted in the level of HDL cholesterol, and LDL peak particle diameter before and after treatment.结论部分:是作者发表观点和见解,给读者的精髓部分1.归纳性说明研究结果或发现2.结论性说明结果的可能原因、机理或意义3.前瞻性说明未解决的问题一、结论部分时态1.过去时(1)涉及本研究的内容(2)涉及他人研究过程的内容(3)作者认为只适用于本研究环境和条件的结论2.现在时(1)指示性说明(2)普遍接受的思想、理论或结论(3)作者认为本研究结论具有普遍意义(4)前瞻性说明举例:Our findings indicate that hepatitis C is a progressive disease [指示性说明- 现在时],but only a few died during the average 20.4 years after the initiation of injection drug use [本试验过程中发生的事- 过去时]. Antiviral treatment to eradicate the virus and halt the progression of diseases is indicated in this group of patients [ 作者认为具有普遍意义的结论- 现在时].二、结论部分常用句型1.结果提示…:These results suggest that…举例:These data confirm the presence of at least two major HCV genotypes in Nigeria.2.结果支持或反对某种观点:These results support the ideathat…;These results fail to support the idea that…举例:These results do not support the idea that treatment to lower cholesterol concentration cause mood disturbance.3.表示观点的确定或不确定性:There is no evidence that…;It islikely/unlikely that …举例:There is no evidence that NIDDM produce any change in bone metabolism or mass.4.具有…意义:Be of great (some/little/no) clinical significance in…to …举例:The detection of p53 gene is of great clinical significance in tumor diagnosis.5.前瞻性说明:…remain to be further studied;It is remains to be proved that …举例:However, the relation of insulin resistance to hypertension remains to be further studied.6.插入语:This is the first case of pancreas divisum.举例:This is the first case, to our knowledge, of pancreas divisum.小结中文是关键→符合英语习惯→不用简单句→注意词语的用法→注意时态。

某社区老人体质量指数对高血压、高血糖的影响调查

某社区老人体质量指数对高血压、高血糖的影响调查
oxygen therapy for adult(HFNC,18 cases) were retrospectively analyzed. Results and Conclusion
The use of corticosteroids
and HFNC had no effect on the days needed for absorption of pulmonary lesions.The effects of short-term hormone therapy and

希,

豫,
等 . 基于微信的 Webquest 教学模式在武汉
市某医院胸外科教学中的应用[J]. 医学与社会,
2018(5):
78-80.
[3]李祥兆 .WebQuest:一种新型的网络探究学习模式[J]. 现代远距离
教育,
2005(6):
21-23.
[4]李
科 ,汪
矗 ,谢
琳 ,等 . 基于网络环境下 CBL 联合 PBL 在
疗;合并脑梗死、脑出血等;近期接受过影响观察指标的相关治
管使血液缓慢溢出。
1.3
高 血 压 诊 断 标 准 :收 缩 压(SBP)≥ 140 mmHg,舒 张 压
(DBP)≥ 90 mmHg。
高血糖诊断标准:
随机血糖 ≥ 11.1 mmol/L[2]。
1.4
2 559 名,根据 BMI 的不同将研究对象分为 4 组。偏瘦组(BMI <
To analyze the treatment of adult patients with coronavirus disease 2019(COVID-19). Methods

肺癌诊断及治疗英文版护理课件

肺癌诊断及治疗英文版护理课件

Nursing care for lung cancer
Psychological care for lung cancer patients
01
Provide emotional support
It is essential to offer emotional support to lung cancer patients,
as they may experience anxiety, fatigue, and depression due to
the diagnosis
02
Inform and educate
It is important to provide information and education about lung
Epiology of lung cancer
Incident
Lung cancer is one of the most common cancers in the world, accounting for about 13% of all cancers The incidence rate is highest in developed countries and is increasing in developing countries
situation and provide resources for coping with stress and
negative emotions
Pain management in lung cancer patients
01
Assess paint
Regularly assess patients' paint levels to identify and manage any paint they may be experiencing

穴位贴敷联合中药热奄包治疗1例慢性胃炎腹胀患者的护理体会

穴位贴敷联合中药热奄包治疗1例慢性胃炎腹胀患者的护理体会

http :/ / 中西医结合护理Chinese Journal of Integrative Nursing2023 年第 9 卷第 1 期Vol.9, No.1, 2023OPEN ACCESS穴位贴敷联合中药热奄包治疗1例慢性胃炎腹胀患者的护理体会徐春艳1, 黄砚萍2(1. 中国中医科学院西苑医院 急诊科, 北京, 100091; 2. 中国中医科学院西苑医院 脾胃科, 北京, 100091)摘要: 本文回顾1例慢性胃炎腹胀患者的中医护理措施。

根据中医辨证基础理论,分析患者腹胀发生原因,选用适宜中医护理技术穴位贴敷联合中药热奄包,有效缓解临床症状,患者胃肠道症状评定量表(GSRS )评分由13分降至2分。

关键词: 慢性胃炎; 腹胀; 穴位贴敷; 中药热奄包中图分类号: R 248.1 文献标志码: A 文章编号: 2709-1961(2023)01-0088-03Nursing of a patient with chronic gastritis and abdominaldistension treated with acupoint application combined withChinese herbal medicine warm compress therapyXU Chunyan 1,HUANG Yanping 2(1. Department of Emergency , Xiyuan Hospital of China Academy ofChinese Medical Sciences , Beijing , 100091;2. Department of Spleen-Stomach Diseases , Xiyuan Hospital of China Academy ofChinese Medical Sciences , Beijing , 100091)ABSTRACT : This paper reviewed the experience of acupoint application combined with Chineseherbal medicine warm compress therapy and nursing cooperation for a patient with chronic gastri⁃tis and abdominal distension. Based on Traditional Chinese Medicine theory of syndrome differen⁃tiation and cause analysis of abdominal distension , appropriate technology of TCM nursing includ⁃ing acupoint application and warm compress therapy were selected to relieve the clinical symptom of the disease and comfort of the patient. The score of Gastrointestinal Symptom Rating Scale (GSRS ) decreased from 13 to 2 points after a 14-day treatment.KEY WORDS : chronic gastritis ; abdominal distension ; acupoint application ; Chinese herbal medicine warm compress慢性胃炎属中医“痞满”“胃脘痛”“嘈杂”“噫气”等范畴,1989年10月全国第五届脾胃病学术交流会将其纳入“胃痞病”范畴,临床表现以脘腹胀满为主,兼上腹疼痛、嗳气、恶心、食欲减退等[1]。

中风后肩手综合征的火龙罐治疗及护理进展

中风后肩手综合征的火龙罐治疗及护理进展

2022年第8卷第10期Vol.8,No.10,2022中西医结合护理Chinese Journal of Integrative Nursing中风后肩手综合征的火龙罐治疗及护理进展刘春艳,杨燕妮,罗丽华,乔莉晓(北京中医药大学深圳医院(龙岗)脑病中心,广东深圳,518000)摘要:本文总结中风后肩手综合征的火龙罐治疗及护理进展,归纳了中风后肩手综合征的火龙罐治疗的作用机制、操作方法以及护理要点,以期为火龙罐治疗肩手综合征的临床护理提供参考。

关键词:中风;肩手综合征;火龙罐;穴位;体位;心理护理中图分类号:R473.5文献标志码:A文章编号:2709-1961(2022)10-0051-04Progress of Fire-dragon moxibustion therapyand nursing of shoulder-hand syndromeafter strokeLIU Chunyan,YANG Yanni,LUO Lihua,QIAO Lixiao(Center for Encephalopathy,Shenzhen Longgang Hospital Beijing University ofChinese Medicine,Shenzhen,Guangdong,518000)ABSTRACT:This paper reviewed the study of Fire-dragon moxibustion therapy and nursing of shoulder-hand syndrome after stroke.The mechanism and operation method of Fire-dragon moxi⁃bustion therapy,as well as nursing cooperation,were summarized,in order to provide reference for clinical treatment and nursing practice.KEY WORDS:stroke;shoulder-hand syndrome;Fire-dragon moxibustion;body position;psychological care脑卒中有较高致残率与致死率,肩手综合征是其常见上肢功能并发症。

升高高密度脂蛋白胆固醇在心血管剩余风险管理中的研究进展_孔嵌蚺

升高高密度脂蛋白胆固醇在心血管剩余风险管理中的研究进展_孔嵌蚺

心血管剩余风险,是指以目前循证为指导的治疗后[低密度脂蛋白胆固醇(LDL-C )、血压及血糖达标],仍发生与血脂异常相关的大血管、微血管事件风险。

有研究报道,升高高密度脂蛋白胆固醇(HDL-C )可能使心血管疾病患者进一步获益,本文就此观点的研究现况做一综述。

1HDL-C 与动脉粥样硬化HDL-C 是心血管事件的独立预测因素[1],HDL-C 每升高1mg /mL ,心血管风险降低2%~3%,其机制可能是[2]:HDL-C 介导胆固醇逆向转运,将外周组织中多余的胆固醇转移至肝脏进行分解代谢;其次可通过阻断巨噬细胞吞噬LDL-C 形成泡沫细胞、抑制炎症反应、改善血管内皮功能、抗血栓形成等机制发挥抗动脉粥样硬化作用。

从2001年起多项试验致力于升高HDL-C ,观察心血管剩余风险降低情况。

2烟酸与心血管剩余风险烟酸是升高HDL-C 经典药物,可在LDL-C 达标基础上升高HDL-C 及载脂蛋白A1(ApoA1),从而可能降低心血管剩余风险。

2009年Lee 等[3]在冠心病患者中发现烟酸可使颈动脉斑块面积减少3%。

同年Taylor 等[4]在208例LDL-C 达标的冠心病患者中加用烟酸,14个月后HDL-C 上升18.4%,最大颈动脉中层内膜厚度明显下降,主要心血管事件(包括心肌梗死、心肌血运重建术、急性冠脉综合征)降低4%,提示烟酸可改善颈动脉斑块面积,降低心血管剩余风险,这一作用可能与HDL-C 升高有关。

但上述两项研究样本量偏小,随访时间仅为12~14个月,因而被部分学者质疑。

2011年Aim-High 研究[5]在3414例LDL-C 达标的冠心病患者中随机加用烟酸或安慰剂,3年后烟酸组HDL-C 较基线增加25%,但对急性冠脉综合征、心源性死亡及缺血性脑卒中等主要复合终点事件发生率无影响,缺血性脑卒中发生率甚至高于对照组(1.6%vs .0.9%)。

2013年HPS2-THRIVE 研究[6]纳入了25673例冠心病患者,强化降脂基础上加用烟酸/拉罗皮兰(前列腺素拮抗剂,降低烟酸引起的潮红)或安慰剂,随访3.9年,烟酸组HDL-C 水平升高14%,但对心血管主要终点事件发生率无改善,且糖尿病并发症、新发糖尿病危险度、感染风险、出血风险均有所增加,虽然研究者认为不良反应很可能与前列腺素拮抗剂有致动脉粥样硬化作用相关,但HPS2-THRIVE 结果与Aim-High 是一致的。

缺血性心肌病临床药物治疗进展

缺血性心肌病临床药物治疗进展
6 5
H,Kodama
M。Hui
L,et
a1.Angiotensin I
rat
type l
receptor after
blocker。valsartan.prevented cardiac fibrosis in autoimmune 105~llO Kim S。Yoshiyama M,Lzumi
eardiomyopathy

8 7
antagonist,on in
rats
the
with
progression of left heart
dys・
remodeling
failure[J】.Pharmacology,
2004,72(I):26—32
顾复生.醛固酮对心力衰竭的有害作用与醛固酮(受体)拮抗剂【J1. 中国循环杂志,2002.17(4):264—266

l 1 10
heart
failure;a
nw
look
at
old
therapy【J J.Curt Opin
CardioI,
2004,19(4):301—308 Struthera
giotensin Hunt AD.Aldostemne
blockade
in
heart
failure[J】.J
Renin
An-
K,Ma M。et
a1.Effects
of
pranidipine.a
ventrieular
novel
(HMG—CoA)还原酶抑制剂,抑制HMG—CoA向甲羟戊酸转化, 限制胆固醇生成。由于甲羟戊酸参与蛋白质的脂质修饰、细胞内 DNA合成等多种生物学过程,所以近年来,他汀类药物除了调 脂、抗动脉粥样硬化作用外,其抗MF、防止缺血性心肌病的作用 越来越受人们重视。

吴林晚钠电流

吴林晚钠电流

抗心律失常药物治疗的新方向:晚钠电流与晚钠电流抑制剂作者:于善栋[1] 吴林[1]单位:北京大学第一医院[1]心律失常在总体人群中的患病率约为 5.3%,其预后差别极大,从无症状不影响生活到严重威胁人们的健康和生命。

近年来,各种非药物治疗方法,如射频消融、植入型自动复律除颤器(implantable cardioverter defibrillator ICD)等取得了很大进展,但是药物治疗不仅可以单独治疗心律失常,也可以在射频消融或器械治疗前后多为补充,ICD治疗后也需要药物治疗来减少发电,改善生活质量,因此仍是防治心律失常的主要手段。

一、传统抗心律失常药物的困境传统的抗心律失常药物面临的一个主要问题是其致心律失常作用。

传统的Ⅰ类抗心律失常药物由于同时抑制了心室肌细胞内的峰钠电流(peak INa)和晚钠电流(late INa),心室峰钠电流的抑制使动作电位在心室内的传导速度减慢,增加了折返的发生率,有可能导致单型性室性心动过速。

CAST研究的结果显示, I c类抗心律失常药物氟卡尼、英卡尼、莫雷西嗪使心肌梗死后频繁室性早搏患者病死率上升[1],具有Ⅲ类作用的抗心律失常药物通过抑制钾离子通道而延长动作电位时程(APD)和QT间期,造成心肌细胞跨壁复极离散度(transmural dispersion of repolarization,TDR)增大,易诱发尖端扭转型室性心动过速(torsade de pointes,TdP),使心律失常性病死率增加,胺碘酮能够抑制多种离子通道,对室性和房性心律失常均有抑制作用,可降低器质性心脏病患者的心律失常性死亡,QT间期延长和较低的尖端扭转型室速外发生率较低,但由于其具有具有复杂的药物相互作用和很多不良反应(肺,肝,甲状腺,皮肤)而使总病死率增加[2, 3]。

FDA新近批准的治疗房颤的药物决奈达隆增加心衰患者的死亡率,β阻滞剂虽可减少心律失常性猝死,但对室性心律失常疗效差。

糖皮质激素在肿瘤治疗中的合理应用

糖皮质激素在肿瘤治疗中的合理应用

糖皮质激素在肿瘤治疗中的合理应用摘要糖皮质激素在肿瘤治疗过程中发挥着重要作用,包括作为化疗方案的组成药物直接抗肿瘤、治疗肿瘤的某些合并症和肿瘤治疗相关不良反应等。

本文介绍糖皮质激素在肿瘤治疗中的应用范围、用法及注意事项。

关键词糖皮质激素肿瘤治疗Rational application of glucocorticoids in the treatment of m alignant tumorZHOU Xin-li(Department of Oncology,Huashan Hospital,Fudan University,Shanghai,200040)Abstract Glucocorticoids play an important role in the treatment of m alignant tumor. They exerted direct anti-tumor effects in combined chemotherapy,controlled complications of cancer,and relieved tumor-related adverse reactions. This article introduces the application range,dosage and administration,and precaution of glucocorticoids in treatment of m alignant tumor.Key words glucocorticoid;tumor;therapy糖皮质激素(glucocorticoids,GCs。

以下简称为激素)是由肾上腺皮质分泌的类固醇激素,具有强大的抗炎、免疫抑制和抗过敏作用,在临床上应用广泛,而其合理应用一直是大家关注的话题。

在肿瘤患者治疗过程中,激素也发挥着重要作用,不仅可以作为化疗方案的组成药物直接抗肿瘤,还可以治疗肿瘤的某些合并症和肿瘤治疗相关不良反应。

氨茶碱与华法林在大鼠体内药动学与药效学的相互影响

氨茶碱与华法林在大鼠体内药动学与药效学的相互影响

氨茶碱与华法林在大鼠体内药动学与药效学的相互影响目的考察氨茶碱与华法林在大鼠体内是否存在药动学和药效学的相互作用,为临床上联合用药提供实验依据。

方法华法林对氨茶碱药动学影响实验中,将16只雄性SD大鼠随机分成华法林+氨茶碱合用组(合用组)和氨茶碱组(单用组),每组8只,于给药后不同时间点采集血样,用高效液相色谱法测定茶碱的血药浓度,采用PKBP药代动力学软件包计算药动学参数,并对参数进行统计分析。

氨茶碱对华法林药效学影响实验,将60只雄性SD大鼠按体重随机分成3组,即未用药组、华法林+氨茶碱合用组(A组)和华法林组(B组),每组20只,在最后一次灌胃给药1 h后短尾取血,用全自动凝血分析仪测定血浆凝血酶原时间(PT)、国际标准化比率(INR),实验结果进行统计分析。

结果合用组达峰时间(Tmax)较单用组明显提前,Vd/F差异有统计学意义(P 0.05)。

A 组和B组较未用药组PT、INR值比较差异有统计学意义(P 0.05),但合用组大鼠的INR高值相对较多。

结论氨茶碱或茶碱与华法林联合使用时,氨茶碱或茶碱血药浓度监测采血时间(峰浓度)可能需要提前,同时更应密切监测患者的INR值,以便及时发现有严重出血倾向的患者,调整华法林的用量或采取补救措施,确保华法林使用的安全有效。

[Abstract] Objective To investigate interaction of aminophylline and warfarin on the pharmacokinetics and pharmacodynamics in rats so as to provide experimental evidence for clinical combination therapy. Methods During the experiment of warfarin on the aminophylline pharmacokinetic effects,16 male SD rats were randomly divided into warfarin + aminophylline combined group (combined group,n = 8)and aminophylline group (alone group,n = 8). Blood samples of rats in both groups were collected at different time points after administration. Blood concentration of theophylline was detected by HPLC. Pharmacokinetic parameters of theophylline were derivated by using PKBP pharmacokinetic packages,and the parameters were statistically analyzed. 60 male SD rats were randomly divided into three groups,namely untreated group (n = 20),warfarin + aminophylline combined group (group A,n = 20)and warfarin group (group B,n = 20)in the experiment of aminophylline on the warfarin pharmacodynamic effects. Blood samples of rats in three groups were collected at the last administered orally 1 h after gavage administration. PT and INR values were determined by automatic coagulation analyzer,and the experimental results were statistically analyzed. Results Tmax of aminophylline of combination group was significantly ahead,there was statistically significant difference in Vd / F (P 0.05). Compared with the untreated group,PT and INR values of Group A and group B were significantly different(P 90%,与蛋白大量结合,游离华法林为0.5%~3%。

氟哌噻吨美利曲辛片治疗乳腺癌改良根治术后化疗患者焦虑的效果及对应激反应的影响

氟哌噻吨美利曲辛片治疗乳腺癌改良根治术后化疗患者焦虑的效果及对应激反应的影响

临床与基础研究氟哌嗟吨辛片治疗癌根治术后疗患者焦虑的及对应激反应的影响许桂峰,吕京,陈洪杰,高登鹏,冯至真基金项目:廊坊市科学技术研究与发展计划项目(2019013018$作者单位:065099河北廊坊,廊坊市人民医院肿瘤科(许桂峰))065099河北廊坊,廊坊市第三人民医院呼吸科(吕京);065099河北廊坊,廊坊市人民医院普外科(陈洪杰,高登鹏))050017河北石家庄,河北医科大学临床医学院(冯至真)第一作者:许桂峰,男,本科,主治医师,研究方向:乳腺肿瘤学,Email:x uguifeng448@通信作者:陈洪杰,男,本科,主任医师,研究方向:普外科疾病诊治,EmW:che?2597766@163口om【摘要】目的探讨氟哌嗟吨美利曲辛片(黛力新)治疗癌改良根治术后化疗患者焦虑的效果及对应激反应的影响&方法选择2018年9至2020年1月廊坊市人民医院收治的乳腺癌改良根治术后化疗患者96例作为研究对象,根据时间点分为对照组(n=48例,2018年9月至2019年4月)和观察组(n=48例,2019年5月至2020年1月)&对照组给予心理干预治疗,观察组给予心理治疗与黛力新疗法,比较两组患者抑郁自评量表(SDS)、焦虑自评量表(SAS)分、应激反应及生活质量&结果两组治疗后2估,心理评分治疗前(P<0.05))组SDS、SAS量表评分对照组(P<0.05),应激反应一氧化氮(NO)%血清皮质醇(Cor)水平低于对照组(P<0.05),超氧化物歧化酶(SOD)对照组(P<0.05),生理%心理%独立性%环境及社会关系领域评分对照组(P<0.05)o结论心理治疗联合黛力新口服癌根治疗患者心理焦虑及应激反应,提疗后生活质量&【关键词】氟哌廛吨美利曲辛片)联合疗法)心理干预;乳腺癌改良根治术)术后化疗;焦虑症;应激反应dot:10.396^^lPssn.1674-4136.2021.01.017文章编号:1674-4136(2021)01-0086-04Effect of combinee therapy with Flupeetixol and Melitracen Tablets on stress response of patients aftermodifiee radical mastectomy XU Guifeng',LYU Jing2,CHEN Hongjie3,GAO Dengpeng3,FENG Zhizhen4.(1.Department of Oncology,Langfang People's Hospital,Langfang065099,China;2.Department of Respiratory,Langfang Third People’s Hospital,Langang065099,China;3.Departz72ent of General Surgery,Langfang people'sHospital,Langfang065099,China;4.The Clinical Mednine College,Hebei Medical University,Shfiazhuang050017,Ch-na)Correspooding author:CHEN Hongjie,Email:chen2597766@163dob'Abstract]Objective To investigate the eOect of flupentixol and melitroxine tablets(Dailysine)inthe treatment of anxiety in patients with breast cancer WI cz modified radical mastectomy and its influence onstress response.Methods Ninety-sin patients undergoing chemotherapy Wter modified radical mastectomy forbreast cancer admitted to Langfang People's Hospital from September,2018to Januay,2020were selected assubjects,and were divided into control groups(n-48cases,September2018to Apil,2019)and theobservation group(n-48cases,May,2019to Januay,2020).The control group was given psychologicalintervention treatment,and the observation group was given psychotherapy combined with Deanxit combinedtherapy.The two groups were compared with the self-rating depression scale(SDS),self-ra/ng anxiety scale(SAS)scores,stress response and quality of life.R essUs The psychological scores of the two groups were lower than that before treatoent/ter Weatoent(P<0.05);the SDS and SAS scales of the obseev/on group were lower than those of the control group after Weatoent(P<0.05);The level of nitric oxide(NO)and serum cortisol(Cor)in the aggravvod reaction was lower than that of the control group(P<0.05);the supeexibe dismutase(SOD)level of the observation group was higher than that of the control group/ter Weatoent(P< 0.05),the scores of physiology,psychology,independence,environment and social relations were higher than those of the conWoi group(P<0.05).Conclusions Deanxit combined therapy can reduce the psychological Puctua/on and stress response of patients/ter modified radical mastectomy for beast cancer and improve the quality of life/ter chemotherapy.'Key words]FlupenCxol and melitracen tablets;Combination therapy;Psychological intervention;Modified radical mastectomy for beast cancer;Postoperative chemotherapy;Anxiety;Stress response手术刺激、放化疗反应、躯体外形改变都会导致乳腺癌患者出现以焦虑、抑郁为主的心理应激反应,而焦虑、抑郁也是影响乳腺癌患者预后的重要因素之一⑴。

微脉冲激光治疗仪联合雷珠单抗玻璃体腔注射对糖尿病视网膜病变患者的治疗效果分析

微脉冲激光治疗仪联合雷珠单抗玻璃体腔注射对糖尿病视网膜病变患者的治疗效果分析

生命科学仪器 2023年第21卷/第5期技术与应用83作者简介:何艳艳,女,甘肃天水,1980.02,汉族,本科,副主任医师,研究方向眼科白内障及眼底病,邮箱:82197635@q q .c o m ㊂王擒虎,性别:男,籍贯:甘肃甘谷,出生年月:1974-08-13,民族:汉族,学历:本科,职称:副主任医师,研究方向:内分泌,邮箱:86531311@q q.c o m ㊂甘肃省卫生行业科研项目,项目编号G S W S K Y 2023-49,科研题目:双波长低强度激光治疗糖尿病创面愈合的应用基础研究,项目类别:科研管理微脉冲激光治疗仪联合雷珠单抗玻璃体腔注射对糖尿病视网膜病变患者的治疗效果分析何艳艳1 王擒虎2通讯作者(1.甘肃省第三人民医院眼科,甘肃兰州7300202.甘肃省第三人民医院内分泌科,甘肃兰州730020)摘要 目的:分析微脉冲激光治疗仪联合雷珠单抗玻璃体腔注射对糖尿病视网膜病变(D i a b e t i c r e t i n o p a t h y,D R )患者的治疗效果㊂方法:收治2022年1月-2023年12月间80例D R 患者,随机抽签法分2组,每组40例,对比2组临床效果㊂结果:治疗前2组患者临床指标㊁中央动脉动力学参数㊁生存质量㊁H b A 1c ㊁m A l b 水平对比(P >0.05);治疗后2组患者临床指标㊁中央动脉动力学参数㊁生存质量㊁H b A 1c ㊁m A l b 水平对比(P <0.05)㊂结论:为糖尿病视网膜病变病患选用微脉冲激光治疗仪联合雷珠单抗治疗后,可以加快病患症状缓解进程,帮助视力恢复,安全性佳,所取得的临床价值较确切,能够满足病患需求,值得临床推广应用㊂关键词 微脉冲激光治疗仪;雷珠单抗玻璃体腔注射;糖尿病视网膜病变A n a l y s i s o f t h e r a p e u t i c e f f e c t o f m i c r o p u l s e l a s e r t h e r a p yc o m b i n ed w i t h i n t r a v i t re a l i n j e c t i o n of l e i z u m a b i n p a t i e n t s w i t h d i a b e t i c r e t i n o p a t h yH e Y a n y a n 1,W a n g C a p t u r e s t h e T i ge r 2(1.O p h t h a l m o l o g y D e p a r t m e n t o f t h e T h i r d P e o p l e 's H o s p i t a l o f Ga n s u P r o v i n c e L a n z h o u 7300202.E n d o c r i n o l o g y D e p a r t m e n t o f t h e T h i r d P e o p l e 's H o s p i t a l o f Ga n s u P r o v i n c e L a n z h o u 730020)ʌAb s t r ac t ɔO b j e c t i v e :T o a n a l y z e t h e t h e r a p e u t i c e f f e c t o f m i c r o p u l s e l a s e r t h e r a p y c o m b i n ed w i t h i n t r a v i t re a l i n j e c t i o n of l e -i z u m a b o n d i a b e t i c r e t i n o p a t h y .M e t h o d 80p a t i e n t s w i t h d i a b e t e s r e t i n o p a t h y a d m i t t e d f r o m J a n u a r y 2022t o D e c e m b e r 2023w e r e r a n d o m l y d i v i d e d i n t o t w o g r o u p s ,40p a t i e n t s i n e a c h g r o u p ,a n d t h e c l i n i c a l e f f e c t s o f t h e t w o g r o u ps w e r e c o m p a r e d .R e s u l t s :T h e t i m e o f s y m p t o m r e s o l u t i o n ,t r e a t m e n t e f f e c t a n d c o m p l i c a t i o n r a t e o f 2g r o u p s w e r e c o m pa r e d (P <0.05).B e f o r e t r e a t m e n t ,t h e c l i n i c a l i n d e x e s ,c e n t r a l a r t e r y d y n a m i c p a r a m e t e r s a n d q u a l i t y o f l i f e o f 2g r o u ps w e r e c o m p a r e d (P >0.05).A f t e r t r e a t m e n t ,t h e c l i n i c a l i n d e x e s ,c e n t r a l a r t e r y d y n a m i c p a r a m e t e r s a n d q u a l i t y of l i f e o f 2g r o u p s w e r e c o m p a r e d (P <0.05).C o n c l u s i o n :Th e c o m bi n a t i o n o f m i c r o p u l s e l a s e r t h e r a p ya n d l e i z u m ab f o r d i a b e t ic r e t i -n o p a t h y p a t i e n t s c a n a c c e l e r a t e t h e p r o c e s s o f s y m p t o m r e l i e f ,h e l p v i s i o n r e c o v e r y ,g o od s a fe t y,t h e c l i n i c a l v a l u e o b t a i n e d i s m o r e a c c u r a t e ,c a n m e e t t h e n e e d s o f p a t i e n t s ,w o r t h y o f c l i n i c a l p r o m o t i o n a n d a p pl i c a t i o n .ʌK e y wo r d s ɔM i c r o p u l s e l a s e r t h e r a p y a p p a r a t u s ;I n t r a v i t r e a l i n j e c t i o n o f l e i z u m a b ;D i a b e t i c r e t i n o p a t h y 中图分类号:R 827.25 文献标识码:A D O I :10.11967/2023211017引言糖尿病视网膜病变(D i a b e t i c r e t i n o p a t h y,D R )是糖尿病常见并发症,主要由视网膜损伤引起,发病率约占糖尿病的30%㊂早期症状不明显,患者视网膜可能存在血管渗漏㊁肿胀㊁视野轻微受损等问题,随着病情进展,患者视网膜新生血管异常生长,在一定程度上引起出血㊁瘢痕㊁脱离等问题,严重损害视力,导致青光眼㊁失明等[1-2]㊂糖尿病视网膜病变患者视网膜血管脆弱,且容易发生血管阻塞问题,造成眼球内血管渗漏㊁缺血,导致视网膜中央区黄斑病变,继发黄斑水肿,出现视野模糊㊁双重视觉㊁视力降低等症状[3-4]㊂目前,临床较为常用的治疗方法有眼底激光治疗㊁玻璃体内注射治疗㊁手术治疗等[5]㊂纵观以往治疗效果,虽然上述方法均能够改善患者症状,促进患者视力恢复,但单独应用效果有限㊂鉴此,本研究以探讨微脉冲激光治疗仪联合雷珠单抗玻璃体腔注射的临床疗效,现报道如下㊂1 资料与方法1.1 一般资料 收治2022年1月-2023年12月间80例D R 患者,随机抽签法分2组,每组40例㊂对照组男㊁女分别19ʒ11例;年龄47-79岁,中位技术与应用生命科学仪器 2023年第21卷/第5期84值(58.91ʃ8.42)岁;体重51-72k g,中位值(60.31ʃ6.29)k g ;糖尿病病程0.8-14.5年,中位值(7.21ʃ2.36)年㊂观察组男㊁女分别17ʒ13例;年龄46-79岁,中位值(57.86ʃ8.36)岁;体重50-72k g ,中位值(60.09ʃ6.16)k g;糖尿病病程0.7-14.5年,中位值(7.19ʃ2.28)年㊂2组资料可比(P>0.05)㊂纳入标准:(1)组间患者病症均符合‘我国糖尿病视网膜病变临床诊疗指南(2014年)“[6]中的病症指征,出现视网膜新生血管㊁微血管瘤病变㊁出血等;(2)将血压水平控制在收缩压ɤ130m m H g 且舒张压ɤ80m m H g,血糖指标控制在ɤ7.0m m o l /L ,餐后血糖8~9m m o l /L ;(3)患者均具有良好精神,言语功能㊂排除标准:(1)合并青光眼及视网膜脱离㊁白内障等视神经疾病;(2)出现视网膜脱离,屈光间质浑浊等,无法采用视网膜激光光凝治疗者;(3)肝功异常;(4)药物过敏;(5)合并严重精神或心理疾病者;(6)合并严重原发性疾病(肝㊁肾㊁造血系统等);(7)妊娠期或哺乳期患者㊂研究对象及家属均已知晓此次研究,并签署知情同意书,且已呈交我院伦理会㊂1.2 方法 对照组:采用单纯眼底微脉冲黄激光仪(I Q 577,台湾科林公司)治疗,治疗时参数时间为, O N 键,间隔1m s 时间 O F F ,负载率15%,波长577n m ,功率由小到大,若无反应,加大功率,直到出现淡白色光凝斑为止,所有患者均采用一次视网膜激光光凝治疗,且随访6个月㊂观察组:采用微脉冲激光治疗仪联合雷珠单抗玻璃体腔注射治疗,医护人员为患者球内注射雷珠单抗(生产厂家:N o v a r t i s P h a r m a S t e i n A G ,产品规格10m g/m l ,每瓶装量0.165m l ,1支/盒)㊂在患者角巩膜缘后部位进行注射,待患者注射完毕后,需对患者进针区域进行按压,同时还需对该部位进行适量涂抹涂妥布霉素地塞米松眼膏(生产厂商:齐鲁制药有限公司;批准文号:国药准字H 20020496),待使用7d 后,如果患者眼部症状平稳,且未出现不良临床表现,可实施微脉冲激光治疗,其方式与对照组无异议㊂1.3 观察指标(1)症状消失时间:即对患者渗出吸收㊁视网膜水肿㊁眼底出血症状消失时间进行统计;(2)临床指标:即对患者治疗前后视网膜新生血管荧光素渗漏面积㊁视力及黄斑区视网膜厚度指标进行检测,其中以视力检测表检测视力水平;以Z e i s s -O C T 仪器检测黄斑区视网膜厚度;以眼底荧光素血管造影仪检测视网膜新生血管荧光素渗漏面积㊂(3)血流动力学:采用(L O G I Q 9(G E );厂家:上海三崴医疗设备有限公司)彩色多普勒超声诊断仪诊断中央动脉动力学参数㊂(4)生存质量:采用中文版低视力者生存质量量表(C L V Q O L)[7]评价患者生存质量㊂(5)H b A 1c 和m A l b 检测:于治疗前及治疗后采集两组患者晨起空腹静脉血5m l,采用硼酸亲和色谱层析法检测糖化血红蛋白(g l y c o s yl a t e d h e m o -gl o b i n ,H b A l c )水平,检测2次取平均值㊂术前及术后取患者晨起中段尿30m l,采用速率散色法检测尿尿微量白蛋白(u r i n a r y mi c r o a l b u m i n ,m A l b )㊂(6)治疗效果:显效:患者视网膜水肿症状基本消失,同时相关病症均已得到治愈,患者视力恢复正常;有效:患者视网膜水肿症状基本得到改善,且相关病症均得到治愈,视力得到初步改善;无效:患者水肿症状以及相关病症均未发生改变,且部分呈现恶化趋势㊂有效率=(显效+有效)/该组总人数ˑ100%㊂(7)并发症:包括:前房炎症反应㊁瞳孔损伤㊁视网膜脱落㊁色觉异常㊂1.4 统计学方法 采用S P S S 20.0软件分析㊂计量资料以(x ʃs)描述,组间以独立样本t 检验,组内以配对t 检验,计数资料以χ2检验,P <0.05为具有统计学意义㊂2 结果2.1 2组患者症状消失时间对比 如表1所示,2组患者症状消失时间对比(P <0.05)㊂表1 2组患者症状消失时间对比[(x ʃs),周]组别例数(n )渗出吸收视网膜水肿眼底出血对照组403.88ʃ0.435.78ʃ0.4312.55ʃ2.12观察组402.21ʃ0.234.21ʃ0.3310.11ʃ2.22t 21.66018.3205.0270P<0.001<0.001<0.0012.2 2组患者临床指标对比 如表2所示,治疗前2组患者临床指标对比(P >0.05);治疗后2组患者临床指标对比(P <0.05)㊂2.3 2组患者中央动脉动力学参数 如表3所示,治疗前2组患者中央动脉动力学参数对比(P>0.05);治疗后2组患者中央动脉动力学参数对比(P <0.05)㊂2.4 2组患者生存质量对比 如表4所示,治疗前2组患者生存质量对比(P >0.05);治疗后2组患者生存质量对比(P <0.05)㊂2.5 2组患者H b A l c 与m A l b 水平对比 如表5所示,治疗前2组患者H b A l c 与m A l b 水平对比(P>0.05);治疗后2组患者H b A l c 与m A l b 水平对比(P <0.05)㊂生命科学仪器 2023年第21卷/第5期技术与应用852.6 2组患者治疗效果对比 如表6所示,2组患者治疗效果对比(P <0.05)㊂表2 2组患者临床指标对比(x ʃs)组别例数视网膜渗漏面积(m m 2)视力黄斑区视网膜厚度(μm )治疗前治疗后治疗前治疗后治疗前治疗后对照组406.22ʃ1.114.32ʃ0.560.22ʃ0.040.45ʃ0.05374.45ʃ45.45288.45ʃ22.34观察组406.32ʃ1.233.21ʃ0.330.23ʃ0.050.73ʃ0.05375.67ʃ46.56232.23ʃ20.22t 0.38210.8000.98825.0400.11911.800P0.705<0.0010.326<0.0010.906<0.001表3 2组患者中央动脉动力学参数(x ʃs)组别例数P S V (c m /s)E D V (c m /s)M V (c m /s)P IR I治疗前治疗后治疗前治疗后治疗前治疗后治疗前治疗后治疗前治疗后对照组408.33ʃ1.2210.23ʃ2.232.88ʃ0.453.46ʃ0.563.98ʃ0.455.88ʃ0.340.84ʃ0.150.67ʃ0.231.54ʃ0.451.32ʃ0.32观察组408.31ʃ1.2413.44ʃ2.122.86ʃ0.444.15ʃ0.553.88ʃ0.547.97ʃ0.550.83ʃ0.140.54ʃ0.111.55ʃ0.551.05ʃ0.21t 0.0736.5980.2015.5600.90020.4400.3083.2250.0894.461P0.942<0.0010.841<0.0010.371<0.0010.7590.0020.9290.000表4 2组患者生存质量对比[(x ʃs),分]组别例数远视㊁观感及移动精细动作调节能力日常生活能力总分治疗前治疗后治疗前治疗后治疗前治疗后治疗前治疗后治疗前治疗后对照组4025.55ʃ4.3430.23ʃ5.3412.02ʃ1.3413.23ʃ0.758.99ʃ1.2312.34ʃ1.8913.34ʃ2.4414.45ʃ0.4560.43ʃ8.3471.34ʃ4.23观察组4025.45ʃ4.3435.67ʃ4.5611.67ʃ1.2314.99ʃ1.568.87ʃ1.2314.77ʃ1.5613.23ʃ2.5515.66ʃ0.3459.45ʃ3.3480.89ʃ4.34t 0.1034.9001.2176.4310.4366.2710.19713.5700.6909.966P0.9180.0000.227<0.0010.664<0.0010.844<0.0010.492<0.001表5 2组患者H b A l c 与m A l b 水平对比(x ʃs)组别例数H b A l c (%)m A l b (m g/d L )治疗前治疗后治疗前治疗后对照组408.33ʃ1.117.32ʃ0.562.22ʃ0.042.15ʃ0.05观察组408.34ʃ1.236.21ʃ0.332.23ʃ0.051.73ʃ0.05t 0.03810.8000.98837.570P 0.970<0.0010.326<0.0012.7 2组患者并发症发生率对比 如表7所示,2组患者并发症发生率对比(P <0.05)㊂表6 2组患者治疗效果对比(n ,%)组别例数(n )显效有效无效有效率对照组4020101030(75.00)观察组402910139(97.50)χ2P表7 2组患者并发症发生率对比(n ,%)组别例数(n)前方炎症反应瞳孔损伤视网膜脱落色觉异常不良率对照组4022127(17.50)观察组40112(5.00)χ2P3 讨论糖尿病为常见慢性疾病的一种,该病一经发病,患者需终生治疗㊂该病的发生与遗传㊁患者饮食㊁生活习惯等联系较为密切[8-9]㊂患者发病后,机体糖代谢功能紊乱,血液粘稠度提升,随病情进展,会致使患者机体内众多系统及器官功能发生障碍,诱发多种并发症,危及患者生命[10-11]㊂视网膜病变为糖尿病严重并发症的一种,该症产生的原因主要为患者血糖长时间维持高水平状态,糖代谢紊乱,从而造成血管组织遭受破坏,进而致使视网膜微血管表现出局部视网膜㊁视乳头缺血㊁血管增生等变化[12-14]㊂雷珠单抗作为抑制药物,尤其是针对V E G F 所发挥的抑制功效较强,其分子量较小,极易穿透视网膜,能够很好的抑制新生血管的生成,并能够使血管通透性下降,将毛细血管渗漏情况降至最小化,继而会对血-视网膜屏障通透性作出调节,加快视网膜水肿现象的消退进程[15]㊂微脉冲激光治疗仪弥补了传统激光治疗的不足,减少对组织的损伤,保护正常视力功能[16-17]㊂本文将微脉冲激光治疗仪㊁雷珠单抗两种疗法相结合后可以达到优化疗效的最终目的,可以将视网膜血管新生有效控制,避免出现出血㊁渗液等不利情况,对多项血清因子亦会作出有效调节,促使V E G F 水平下降,进而控制病症进展,缓解病患的症状[18-20]㊂本文研究结果表示,观察组患者各症状消失时技术与应用生命科学仪器 2023年第21卷/第5期86间较短,由此说明,采用微脉冲激光治疗仪联合雷珠单抗能够显著改善患者症状,促进患者康复㊂彭毅[21]在其文献研究中60例糖尿病视网膜病变患者接受眼底激光治疗后疗效总有效率的96.67%近乎一致,充分说明此次研究结果真实有效㊂本次研究中,治疗后观察组临床指标恢复情况较优,由此可见采用微脉冲激光治疗仪联合雷珠单抗可显著改善视网膜功能及临床症状,增强视力水平[22]㊂本研究中治疗后观察组动脉血流动力学参数显著改善,由此可见,微脉冲激光治疗仪联合雷珠单抗可显著改善患者视网膜中央动脉血流动力学,效果明显㊂林翎等[23]研究结果表示,采用玻璃体腔内注射雷珠单抗联合视网膜激光光凝术可显著改善D R 患者视网膜血流动力学及生活质量㊂与本文研究结果一致㊂此外,微脉冲激光治疗仪联合雷珠单抗在一定程度上可改善患者的生活质量[24-25]㊂本文研究结果发现,治疗后观察组患者生存质量显著升高,由此可见,微脉冲激光治疗仪联合雷珠单抗能够有效改善患者视网膜血流动力学及生存质量㊂H b A 1c 是衡量血压正常的 金标准 ,H b A 1c水平的持续升高会严重影响患者视网膜循环㊂V E G F 水平的升高会导致V H 发生率增加㊂当患者出现肾损伤时,m A l b 水平则会呈升高状态,造成机体损伤㊂本文研究结果发现,观察组患者H b A 1c ㊁m A l b 水平改善明显,由此可见,采用微脉冲激光治疗仪联合雷珠单抗能够有效降低患者机体炎症水平,改善患者血糖水平㊂综上所述,为D R 病患选用微脉冲激光治疗仪联合雷珠单抗治疗后,可以加快病患症状缓解进程,帮助视力恢复,安全性佳,所取得的临床价值较确切,能够满足病患需求,值得临床推广应用㊂参考文献[1]F u n g T H ,P a t e l B ,W i l m o t E G ,e t a l .D i a b e t i c r e t i n o p a t h yf o r t h e n o n -o p h t h a l m o l o gi s t [J ].C l i n M e d (L o n d ).2022,22(2):112-116.[2]L i Y ,M i t c h e l l W ,E l z e T ,e t a l .A s s o c i a t i o n B e t w e e n D i a b e t e s ,D i a b e t i c R e t i n o p a t h y ,a n d G l a u c o m a [J ].C u r r D i a b R e p.2021,21(10):38.[3]胡可可,惠延年,杜红俊.抗V E G F 时代激光光凝治疗糖尿病视网膜病变的应用进展[J ].国际眼科杂志,2023,23(8):1285-1289.[4]张珞妃,霍记平,赵志刚.糖尿病视网膜病变的药物治疗选择[J ].临床药物治疗杂志,2022,20(9):11-17.[5]陈若瑜,曹丹,张良.糖尿病视网膜病变药物治疗研究进展[J ].眼科新进展,2022,42(3):244-248.[6]中华医学会眼科学会眼底病学组.我国糖尿病视网膜病变临床诊疗指南(2014年)[J ].中华眼科杂志,2014,50(11):851-865.[7]吕艳,李娟,谢慧.术前玻璃体内注射雷珠单抗联合视网膜光凝对2型糖尿病视网膜病变的疗效[J ].中华眼外伤职业眼病杂志,2023,45(9):714-720.[8]G r z y b o w s k i A ,B r o n a P ,L i m G ,e t a l .A r t i f i c i a l i n t e l l i ge n c ef o r d i a b e t i c r e t i n o p a t h y s c r e e n i ng :a r e v i e w [J ].E ye (L o n d ).2020,34(3):451-460.[9]梁晓茜,陈王灵,陈运信,等.雷珠单抗辅助视网膜激光光凝治疗糖尿病视网膜病变伴玻璃体积血的疗效及对患者视力和H b A 1c ㊁m A l b 水平的影响[J ].中国医学装备,2023,20(8):88-92.[10]张祖嫣,王峰,苏颖.眼底激光联合雷珠单抗治疗对糖尿病视网膜病变及静脉阻塞引起黄斑水肿患者视力的影响[J ].临床和实验医学杂志,2023,22(6):609-613.[11]Y i n L ,Z h a n g D ,R e n Q ,e t a l .P r e v a l e n c e a n d r i s k f a c t o r s o f d i a -b e t i c r e t i n o p a t h y i n d i a b e t i c p a t i e n t s :A c o m m u n i t y ba s e d c r o s s -s e c t i o n a l s t u d y[J ].M e d i c i n e (B a l t i m o r e ).2020,99(9):e 19236.[12]韩彦辉,赵楠,孟繁超,等.术前玻璃体腔注射康柏西普联合25G +玻璃体切割术治疗增殖性糖尿病视网膜病变[J ].国际眼科杂志,2023,23(10):1732-1736.[13]孙峰,杨学龙,吴兵.雷珠单抗对糖尿病视网膜病变伴新生血管性青光眼的疗效及血清血管内皮生长因子和胰岛素样生长因子-1水平的影响[J ].中国医药导报,2023,20(2):118-121.[14]徐冰,史喜红,白雪.眼底激光联合雷珠单抗对糖尿病视网膜病变及静脉阻塞引起黄斑水肿患者视力情况的影响研究[J ].检验医学与临床,2022,19(7):962-964.[15]C h e n S N ,C h e n S J ,W u T T ,e t a l .R e f i n i n g v i t r e c t o m y f o r pr o -l i f e r a t i v e d i a b e t i c r e t i n o p a t h y [J ].G r a e f e s A r c h C l i n E x p O ph -t h a l m o l .2023,261(12):3659-3670.[16]徐晨,纪丽君,苗林.雷珠单抗联合玻璃体切割对增生性糖尿病视网膜病变玻璃体中V E G F ㊁T F 表达的影响[J ].中国临床医学,2021,28(3):502-506.[17]张丽楠,宋其缘,窦晓燕.23G 微创玻璃体切割术联合雷珠单抗治疗增殖期糖尿病视网膜病变[J ].中国现代手术学杂志,2021,25(5):380-384.[18]王越,李甦雁,张正培.25G+微创玻璃体切割术联合术前不同间隔时间雷珠单抗玻璃体腔注射治疗增生型糖尿病视网膜病变的疗效比较[J ].徐州医科大学学报,2020,40(5):359-362.[19]L i H ,L i u X ,Z h o n g H ,e t a l .R e s e a r c h p r o gr e s s o n t h e p a t h o -g e n e s i s o f d i a b e t i c r e t i n o p a t h y [J ].B M C O ph t h a l m o l .2023,23(1):372.[20]V a l d e z G u e r r e r o A S ,Q u i n t a n a -P ér e z J C ,A r e l l a n o -M e n d o z aM G ,e t a l .D i a b e t i c R e t i n o p a t h y :I m po r t a n t B i o c h e m i c a l A l t e r a -t i o n s a n d t h e M a i n T r e a t m e n t S t r a t e gi e s [J ].C a n J D i a b e t e s .2021,45(6):504-511.[21]胡耀,彭毅.眼底激光治疗糖尿病视网膜病变的效果观察[J ].中国继续医学教育,2021,13(35):102-106.[22]T a u r o n e S ,R a l l i M ,N e b b i o s o M ,e t a l .T h e r o l e o f i n f l a m m a -t i o n i n d i a b e t i c r e t i n o p a t h y:a r e v i e w [J ].E u r R e v M e d P h a r m a c o l S c i .2020,24(20):10319-10329.[23]林翎,卢毓敏,马胜生.雷珠单抗联合眼底激光治疗糖尿病视网膜病变的疗效[J ].实用医学杂志,2021,37(20):2660-2664.[24]H e M ,C h e n H ,W a n g W.R e f r a c t i v e E r r o r s ,O c u l a r B i o m e t r ya n d D i ab e t ic R e t i n o p a t h y :A C o m pr e h e n s i v e R e v i e w [J ].C u r r E ye R e s .2021,46(2):151-158.[25]赵晓明,杨整军,刘珺.银杏叶提取物片联合雷珠单抗对糖尿病视网膜病变血糖㊁血脂和凝血指标的影响[J ].血栓与止血学,2021,27(4):578-580.。

恩度治疗骨肉瘤研究进展综述专家讲座

恩度治疗骨肉瘤研究进展综述专家讲座
抑制新生和再生血管生长连续抑制残余和新生肿瘤细胞
恩度联合放化疗1 + 1 > 2全新抗肿瘤治疗策略
恩度治疗骨肉瘤研究进展综述
第22页
1
2
抗血管生成治疗长周期治疗模式
1.足周期联合给药:使肿瘤血管趋于正常化
血浆渗漏↓ 组织间压↓ 乏氧改进、药品递送↑
放化疗协同增效
2.长周期连续维持 抑制新生和再生血管生长, 不成熟血管退化 长久高效抗血管生成结果是最终切断肿瘤细胞营养供给,长时间压制肿瘤,使肿瘤休眠
肿瘤横切面坏死率
SUV(标准摄取值)
恩度治疗骨肉瘤研究进展综述
第18页
内皮抑素降低骨肉瘤术后肺转移研究
围手术期给予内皮抑素治疗显著降低骨肉瘤术后肺转移发生
恩度治疗骨肉瘤研究进展综述
第19页
内皮抑素抑制肺转移灶形成
Prevention of the progression of pulmonary metastasis by Ad5CMVmEnd.The macroscopic pulmonary metastases were counted 2 weeks after injection of Ad5CMV-mEnd.n =15/group
恩度治疗骨肉瘤研究进展综述
第12页
内皮抑素: 广谱抗血管生成作用
内皮抑素不但仅只作用于VEGF
HIF1-α( VEGF关键触发原因)MMPs(血管芽生和肿瘤转移关键)VEGFA(关键促血管生成因子)neuropilin 1(肿瘤细胞表面VEGFR)FGF-R1(鳞状细胞癌驱动基因)FGF-R2 (鳞状细胞癌驱动基因)EGFR (肺癌驱动基因)bFGF (主要促血管生成因子)Ephrin(肿瘤血管发生和淋巴管生成中一个潜在治疗靶点)…………

针药结合对脑卒中肢体痉挛大鼠大脑皮质BDNF、TrkB、GABAa受体表达的影响

针药结合对脑卒中肢体痉挛大鼠大脑皮质BDNF、TrkB、GABAa受体表达的影响
BDNF) 通过与其高亲和力的酪氨酸蛋白激酶受体
B( tyrosine kinase receptor b,TrkB) 结合可促进 γ-基
丁酸( γ-Aminobutyric acid,GABA) 的 释 放 表 达, 而
外源性 BDNF 增加了 GABA 能中间神经元的兴奋
性。 GABA 与 GABAa 受体在突 触 后 膜 相 结 合 后,
省自然科学基金资助项目(2018JJ2294) -针刺对脑卒中肢体痉挛大鼠 GABAa-BDNF-TrkB-突触可塑性蛋白信号通路的影响;湖南省中医药科研
计划(201828) -从 GABAa-BDNF-TrkB-突触可塑性蛋白信号通路探讨针药结合对脑卒中肢体痉挛大鼠的影响;湖南省研究生科研创新项目
Each treatment group was intervened on the first day after the successful establishment of the model, and continued for 5
days. The scores of neural function and muscle tension of rats in each group were observed and the expression of BDNF,
TrkB,GABAa receptors in cerebral cortex were detected . Results:Compared with the sham-operation group,the scores of
neural function and muscle tension in the model group increased significantly ( P < 0. 01) , and the expression levels of

匹多莫德与抗组胺药联合治疗慢性荨麻疹的临床研究

匹多莫德与抗组胺药联合治疗慢性荨麻疹的临床研究

匹多莫德与抗组胺药联合治疗慢性荨麻疹的临床研究【摘要】目的:探究临床上使用匹多莫德与抗组胺药富马酸卢帕他定联合治疗慢性荨麻疹的临床疗效。

方法:选择我院2016年1月-2016年3月收治的52例慢性荨麻疹患者,随机分为对照组和治疗组各26例。

其中对照组给予富马酸卢帕他定进行治疗,治疗组在对照组治疗基础上再给予匹多莫德分散片。

对比两组患者的临床治疗总有效率以及两组患者出现不良反应的情况。

结果:治疗组的临床总有效率为88.46%,明显高于对照组的65.38%,差异有统计学意义(P<0.05);两组治疗期间均未发生显著的不良反应。

结论:临床上使用匹多莫德与抗组胺药富马酸卢帕他定联合治疗慢性荨麻疹效果明显,且无显著的安全性问题,值得临床应用推广。

【关键词】匹多莫德;抗组胺药;慢性荨麻疹;临床疗效[Abstract] objective:to explore the clinical use of aspirin maud and antihistamines fumaric acid Lou,he set the clinical curative effect of combination therapy of chronic urticaria. Methods:from January 2016 - March 2016,52 cases of chronic urticaria treated patients,randomly divided into control group and treatment group(n = 26). The control group given fumaric acid palmer he treatment,the treatment group treats in the foundation in the control group on to give more moder dispersible tablet. Comparison of two groups of patients with clinical total effective rate and the situation of the two groups of patients with adverse reactions. Results:the clinical total effective rate was 88.46% in treatment group,significantly higher than the 65.38% in the control group,the difference was statistically significant(P < 0.05);The two groups during the treatment,there was no significant adverse reactions. Conclusion:clinical use horse maud and antihistamines fumaric acid Lou,he set the obvious effects of combination therapy of chronic urticaria,and no significant security problems,worth clinical promotion.[Key words] horse maud;Antihistamines. Chronic urticaria. Clinical curative effect慢性荨麻疹(Chronic urticaria,CU)系临床上因各种因素而导致患者皮肤、黏膜小血管及渗透性增加而出现的局限性水肿反应,病程一般在6周以上[1]。

脑功能显像技术在药物成瘾研究中的应用及有关研究进展

脑功能显像技术在药物成瘾研究中的应用及有关研究进展

*基金项目:国家重点基础研究发展计划(973计划)/精神活性物质依赖的生物学基础及防治0(2003CB515400)资助项目**通讯作者:E-m ai:l Sh ijie @bj m u .edu .cn[综述]脑功能显像技术在药物成瘾研究中的应用及有关研究进展*时 杰**赵励彦 陆 林(北京大学中国药物依赖性研究所,北京,100083)摘要 在介绍脑功能显像技术在药物成瘾研究中的应用及国内外有关研究进展的同时,结合我们已完成或正在进行中的研究内容,探讨药物成瘾者在依赖、戒断、复发等不同状态下脑内血流灌注、葡萄糖代谢和神经受体及转运体等发生的形态和功能活动的改变,以寻找与渴求和复发相关的神经核团、神经通路及受体作用系统,进而明确病理性记忆的神经生物学基础,了解依赖和复发过程中神经机制,从而为寻找有效的治疗措施提供理论基础。

关键词 功能影像;正电子发射计算机断层扫描;单光子发射计算机断层扫描;功能性磁共振;阿片;精神兴奋剂RECENT PROGRESS OF BRA I N F UNCTI ONAL I M AG I NG I N DRUG ADD ICTI ONSH I Ji e ,Z HAO L i y an,LU L i n(National Institute on Drug D e p endence ,P eking University ,Beijing,100083)ABSTRACT Functi o na l i m age has been used to exp l o re the neurob i o log ica l m echan is m o f add iction in the past t w o decades .In this rev ie w ,w e w ill d iscuss the app lication and the pr ogress of the Positron E m ission To m ography (PET),S i n g le Photon E m i s sion Co m puted To mography (SPECT )and FunctionalM agneti c Resonance I m ag i n g (M f R I)i n t h e drug abuse .W e also rev ie w our recent findings usi n g PET,SPECT and M f RI in patients w ith opiate w ithdra w al and w ith m ethadone m a i n tenance treat m en.t W e found that the dopa m i n e transporter (DAT)w as sign ificantly decreased i n the bra i n o f subjects w ith hero i n abuse and these changes lasted for si x m onths a fter abstinence fro m drug use ,w hich i n dicates that dr ug abuse can i n duce long -lasti n g i m pair m ent i n the brain .W e a lso observed a si g nifican t decrease o f reg i o na l cerebral blood flo w (r CBF)in b ilateral cerebral fr onta l lobes ,te m pora l lobes ,t h e insula and t h e ipsilatera l basal nuclei i n MDMA sub j e cts .I n our recen t p ilot st u dy ,w e found the functi o na l acti v ati o n i n duced by her o in cues w as sign ificant different i n m any brain area of hero i n add ict and con tro l subjec.t Taken together ,f u ncti o na l i m ages p lay a critica l role in understandi n g the neuronal pr ocesses of addiction and w ill lead the direction i n future research for m edication developm en t of add iction treat m en.tKEY W ORD S f u ncti o na l i m age ;positron e m ission to m ography ;sing le photon e m ission co m puted to mography ;functionalm agne tic resonance i m aging ;op iate ;psychosti m ulant 20世纪90年代以来,随着神经功能影像技术(PET 、SPECT 、M f RI)的发展,使人类有机会能够在活体内研究参与物质成瘾的特殊脑区和核团,这为深入研究药物成瘾的神经生物学机制提供了良好的契机。

不典型重症联合免疫缺陷病的临床研究进展

不典型重症联合免疫缺陷病的临床研究进展

DOI:10.3760/cma.j.issn.0578-13 10.2014.12.006
应多数得到了保留,甚至只是轻微受损,免疫球蛋白的水平 也较典型患者高,特异抗体反应也有相当程度的保留。其他 一些表现也有异于典型者,如不典型ADA—SCID患者常伴有 嗜酸粒细胞增多和高IgE。
基金项目:国家卫生计生委公益性行业科研专项(201402012) 作者单位:400014重庆医科大学附属儿童医院肾脏免疫科 通信作者:赵晓东(Email:zhaoxd530@aliyun.corn)
次,患儿的发病年龄>6个月,或是在6个月内发病,但症状 轻微(无危及生命的临床事件发生),感染较易控制,并生存 至1岁后。另外,患儿1岁以内未进行基因治疗、造血干细 胞移植等免疫重建。简言之,不典型SCID是与典型SCID有 相同致病基因但无典型重症临床表现的一类疾病。Omenn 综合征因表现特殊’加J,诊断和治疗方案较明确,故暂未纳 入。 二、临床特征 不典型SCID患儿的发病年龄3个月一17岁,诊断年龄 10个月一41岁,这与典型SCID患儿6个月以内发病、无替 代或免疫重建治疗、多于1岁内死亡的特点不同。绝大多数 患儿的基因突变由遗传而获得,即基因分析显示亲代为携带 者,同时常常有相关家族史。 感染部位集中在呼吸系统、消化系统、皮肤及中耳鼻窦 等部位。感染的病原体主要为EB病毒、疱疹病毒、水痘病 毒、巨细胞病毒和呼吸道合胞病毒;链球菌、葡萄球菌和铜绿 假单胞菌;念珠菌、贾第鞭毛虫、曲霉菌和卡氏肺孢子虫等。 不典型SCID与典型SCID的感染部位和病原体基本一致。
Buck D,Moshous
D,de Chasseval R,et a1.Severe
deaminase
de6ciency[J].B100d,1998,9l:30.36. [5]Lainka
  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

ORIGINALARTICLEEffects of Combination Therapy with Levamlodipine and Bisoprolol on Stroke in RatsHuan Gui,1Yong-Fei Guo,2Xia Liu,1Jing-Ming Zhang,1Yan-Ling Yang,3Gao-Zhong Huang4&Jian-Guo Liu1 1Department of Pharmacology,Second Military Medical University,Shanghai,China2Department of Reparative and Reconstructive Surgery,Changzheng Hospital,Second Military Medical University,Shanghai,China3Shanghai Institute of Pharmaceutical Industry,National Pharmaceutical Engineering&Research Center,China State Institute of Pharmaceutical Industry,Shanghai,China4Department of Gerontology,Sixth People’s Hospital,Shanghai Jiaotong University,Shanghai,ChinaKeywordsBisoprolol;Combination therapy; Levamlodipine;Stroke.CorrespondenceProf.J.-G.Liu,Department of Pharmacology, Second Military Medical University,325Guo He Road,Shanghai200433,China.Tel.:+86-21-8187-1273;Fax:+86-21-6549-3951;E-mail:jianguoliu2010@andProf.G.-Z.Huang,Department of Gerontology, Sixth People’s Hospital,600Yi San Road, Shanghai200233,China.Tel.:+86-21-8187-1273;Fax:+86-21-6549-3951;E-mail:huanggaozhong@ Received12November2012;revision14 December2012;accepted14December 2012.doi:10.1111/cns.12057Thefirst two authors contributed equally to this work.SUMMARYAim:To examine the effects of combination with levamlodipine and bisoprolol on stroke in rats.Methods:For acute study,Systolic blood pressure(SBP)and heart period(HP)were monitored in conscious stroke prone-spontaneously hypertensive rats(SHR-SP)and sino-aortic denervation(SAD)rats before and after intragastric administration of either drug at a single dose.Rats were subjected to middle cerebral arterial occlusion(MCAO)half an hour after drug administration;sacrificed24h later to measure the infarct size.For long-term study,drugs(either alone or in combination)were delivered via food to SHR-SP.The sur-vival time was recorded.Results:SBP was significantly reduced by combination therapy both in SHR-SP and SAD rats.Neutralization on heart rate(HR)was observed in combina-tion.The drug combination increased baroreflex sensitivity(BRS)and reduced SBP variabil-ity(SBPV).In chronic experiments,the lifespan of SHR-SP rats exposed to the drug combination was longer than that in rats exposed to either drug alone.The infarct area was the smallest in subjects receiving drug combination in SD rats both with and without SAD. Conclusion:Combined use of levamlodipine and bisoprolol produced better protection against stroke.IntroductionStroke is the second leading cause of death worldwide with high rate of disability in survivors who often require lifelong assistance [1].Hypertension is one of the most important risk factors for stroke[2].Antihypertensive treatment could reduce the stroke bination of two or more antihypertensive drugs from dif-ferent classes could achieve identical efficacy with lower doses, and thus decreasing dose-related adverse effects caused by indi-vidual drug[3,4].A previous study from this laboratory in sponta-neously hypertensive rats(SHR)suggested that the best ration of the calcium-channel blocker levamlodipine to the b-blocker biso-prolol is4:1in terms of lowering blood pressure[5].In the present study,we examined the effects of this combination on stroke in rats.Increased blood pressure variability(BPV)and impaired barore-flex sensitivity(BRS)contribute to organ damage as well as the pathogenesis of hypertension and stroke[6,7].We therefore also examined the effects of the combination on BPV and BRS.Materials and MethodsDrugs and AnimalsLevamlodipine besylate was provided by Shihuida Pharmaceutical Group(Baishan,Jilin,China).Bisoprolol fumarate was purchasedfrom Aventis Pharma Group(Haikou,China).Male stroke prone-SHR(SHR-SP)and Sprague-Dawley(SD)rats were obtained from the animal center of the Second Military Medical University and housed in a facility with controlled temperature(23–25°C)and lighting(on:08:00–20:00).Food and tap water were available without restriction.All the animals received humane care in com-pliance with the institution guidelines for the health and care of experimental animals.Measurement of Blood PressureSystolic blood pressure(SBP)and heart period(HP)were con-tinuously recorded as previously described[8].Briefly,rats were anesthetized with ketamine and diazepam.Afloating polyethylene catheter was inserted into the lower abdominal aorta via the left femoral artery for blood pressure measure-ment,and another catheter was inserted into stomach via mid-dle abdominal incision for drug administration[9].The catheters were exteriorized through the interscapular skin.After a2-day recovery period,rats were placed in individual cages with the aortic catheter connected to a pressure transducer via a rotating swivel that allowed the animals to move freely. Blood pressure was recorded after4-h habituation.SBP and HP were determined on line for every heartbeat.The standard deviation of SBP was used as a quantitative parameter of SBP variability(SBPV).The heart rate(HR)was calculated based on HP using the following equation:HR=60000ms/HP.The mean values of these parameters during a period of6h for each rat were used.Determination of BRSBRS was measured in conscious rats as previously described[10] prior to and after drug administration.Briefly,blood pressure was raised by about30mmHg with a proper dose of phenylephrine. The slope with the largest correlation coefficient(r)of HP/SBP was expressed as BRS(ms/mmHg).The mean of two measure-ments was taken as thefinal result.Sinoaortic Denervation(SAD)SAD was carried out in male SD rats(12weeks of age)as pre-viously described[11,12].Briefly,the rats were anesthetized with a combination of ketamine(50mg/kg)and diazepam (5mg/kg)intraperitoneally and then received atropine sulfate(0.5mg/kg,ip)and procaine benzylpenicillin(60000U,im).A midline neck incision was made to denervate aortic barore-ceptors bilaterally.The superior laryngeal nerves were cut near the vagi.The superior cervical ganglia were removed.The aor-tic depressor nerves were sectioned.The carotid sinus barore-ceptors were denervated bilaterally by stripping the carotid bifurcation and its branches followed by the application of 10%phenol(in95%ethanol)to the external,internal,com-mon carotid arteries,and the occipital artery.Sham operation consisted of the midline neck incision and isolation of the neck muscles.Rats were allowed to recover for1month prior to the experiments.Middle Cerebral Arterial Occlusion(MCAO)and Morphological ExaminationMCAO was carried out in SAD rats using a suture-occluded method[13–15]at30min after drug administration.Briefly,rats were anesthetized with3.5%chloral hydrate.A monofilament nylon suture(0.26mm in diameter and40mm in length;Beijing Sunbio Biotech Co.Ltd,Beijing,China)was introduced through an incision of the left common carotid artery in the internal caro-tid artery to occlude the origin of the left middle cerebral arterial for120min.Body temperature was maintained at a physiological level during surgery.For morphological examination,the brain was removed and stored into cold0.1M phosphate buffer(pH7.4)for a few minutes, sliced transversely into seven sections(from the anterior to the posterior),stained with2%2,3,5-triphenyl tetrazolium chloride (TTC)for30min,andfixed with4%paraformaldehyde.The infarct area in each section was measured using a computerized image analysis system.Total infarct area of the brain was estimated by adding the infarct area of each section.Long-Term Treatment in SHR-SPSHR-SP(4months of age)randomly received levamlodipine (1mg/kg/day),bisoprolol(0.25mg/kg/day),a combination of levamlodipine and bisoprolol(1+0.25mg/kg/day),or vehicle control via rat chow.The survival time was recorded.Statistical AnalysisData are expressed as meanÆSD.The differences prior to and after drug administration were evaluated using paired t-test.One-way analysis of variance(ANOVA)with Tukey’s posttest for multiple comparisons was used to analyze the potential difference among drug treatments.Kaplan–Meier analysis was used to estimate sur-vival probabilities.Log-rank testing was used to evaluate the equality of survival curves.P<0.05was considered statistically significant.ResultsEffects of Levamlodipine and Bisoprolol in SHR-SPSBP was significantly decreased by levamlodipine(160Æ8.6 vs.177Æ12.6mmHg,P<0.01),bisoprolol(163Æ10.7vs. 180Æ8.3mmHg,P<0.01),or the combination(156Æ9.6vs. 175Æ12.2mmHg,P<0.01).In comparison with the baseline, the HR was increased by bolus injection of levamlodipine and decreased by bisoprolol.The levamlodipine-induced tachycardia and the bisoprolol-induced bradycardia were temporized by the combination of the two drugs(Figure1B).SBPV was not affected by any treatment(Figure1C).BRS was increased by levamlodi-pine alone(0.53Æ0.069vs.0.32Æ0.034,P<0.01)as well as the drug combination(0.57Æ0.077vs.0.3Æ0.045,P<0.01), but not affected by bisoprolol alone(0.28Æ0.0283vs.0.34Æ0.05)(Figure1D).Effects of Levamlodipine and Bisoprolol in SAD RatsSBP was decreased by levamlodipine or bisoprolol alone,as well as the drug combination in SAD rats(levamlodipine:137Æ12.8 vs.144Æ12.6mmHg,P<0.05;bisoprolol:138Æ7.92vs. 146Æ10.4mmHg,P<0.05;and in combination:129Æ9.54vs. 144Æ12.2mmHg,P<0.01;Figure2A).In comparison with the baseline,the HR was increased by levamlodipine and decreased by bisoprolol.The levamlodipine-induced tachycardia and the biso-prolol-induced bradycardia were temporized by the combination of these two drugs.SBPV was significantly decreased only by the combination treatment,and not by either drug alone(Figure2C).Effects of Levamlodipine and Bisoprolol on Survival of SHR-SPThe lifespan of SHR-SP was prolonged by levamlodipine alone as well as by the drug combination(Figure3A,B).Bisoprolol alone did not affect the survival time.Effects on MCAO-Induced Brain Injury in SD RatsThe infarct area caused by MCAO was decreased by levamlodipine alone and by the drug combination(Figure4).The infarct area in rats receiving the drug combination was smaller than in rats receiving levamlodipine alone.The percentage infarct area relative to the total area was34.9Æ6.84%in the vehicle control,28.0Æ6.00%in rats receiving levamlodipine alone, 26.6Æ12.8%in rats receiving bisoprolol alone,and 22.8Æ10.9%in rats receiving both drugs.Effects on MCAO-Induced Brain Injury in SAD RatsThe infarct area is response to MCAO was decreased by bisoprolol alone and by the combination treatment(Figure5).The percent-age infarct area was36.7Æ4.95%in the vehicle con-trol,30.5Æ10.4%in rats receiving levamlodipine alone, 26.1Æ4.40%in rats receiving bisoprolol alone,and 24.4Æ5.56%in rats receiving both.(A)(B)(C)(D)Figure1Effects of a single dose of Lev(1mg/ kg),Bis(0.25mg/kg)and Lev+Bis(1+0.25mg/kg)on SBP(A),HR(B),SBPV(C) and BRS(D)in SHR-SP.Open bars,before intragstric administration;solid bars,after intragstric administration.Values are expressed as meanÆSD.*P<0.05,**P<0.01versus before administration,n=10in each group.Lev,levamlodipine;Bis, bisoprolol;SBP,systolic blood pressure;HR, heart rate;SBPV,SBP variability;BRS,baroreflex sensitivity;SHR-SP,stroke prone-spontaneously hypertensive rats.(A)(B)(C)Figure2Effects of a single dose of Lev(1mg/kg),Bis(0.25mg/kg)and Lev+Bis(1+0.25mg/kg)on SBP(A),HR(B)and SBPV(C)in SAD rats.Values are expressed as meanÆSD.*P<0.05,**P<0.01versus before administration,n=10in each group.SAD,sinoaortic denervation.DiscussionIn clinical practice,combination therapy with two or more classes of antihypertensive drugs was recommended for hypertension. The advantage of combination regimen includes more rapid blood pressure control and more effective blood pressure reduction.In most cases,the dose could be reduced.As a result,side effects could be decreased.The combination of a b-adrenergic blocker and a calcium antagonist is a common choice[16].Calcium antag-onists are vasodilators and tend to increase HR,while b-blockers decrease HR.Theoretically,the combination of these compounds produces less impact on HR.Here,we showed that the HR is increased by levamlodipine alone and decreased by bisoprolol alone,but no altered in subject receiving both agents in SHR-SP and SAD rats.Baroreflex function is an independent prognostic factor for acute ischemic stroke[17].Other factors,including vascular remodeling,inflammation,and oxidative stress,increase the risk of stroke in patients with hypertension[18].SBPV and BRS con-tribute to organ damage more than high SBP in SHR rats [7,19].(A)(B)Figure3Effects of Lev(1mg/kg/day),Bis(0.25mg/kg/day)and Lev+Bis(1+0.25mg/kg/day)on the stroke death in SHR-SP.(A)Survival curves of all the rats in four groups.Blue for Control,Green for Lev,Yellow for Bis and Purple for Lev+Bis.(B)Histogram for average survival time of SHR-SP in each group. Values are expressed as meanÆSD,n=20in each group,*P<0.05,**P<0.01versus Control.(A)(B)Figure4Effects of Lev(1mg/kg),Bis(0.25mg/kg)and Lev+Bis (1+0.25mg/kg)on the cerebral injury induced by MCAO in SD rats.(A)TTC staining of samples in each group.(B)Infarct area(%)of each group.Values are expressed as meanÆSD,n=10per group, *P<0.05,**P<0.01versus Control.MCAO,middle cerebral arterial occlusion;SD,Sprague–Dawley;TTC,2,3,5,-triphenyl tetrazolium chloride.(A)(B)Figure5Effects of Lev(1mg/kg),Bis(0.25mg/kg)and Lev+Bis (1+0.25mg/kg)on the cerebral injury induced by MCAO in SAD rats.(A)TTC staining of samples in each group.(B)Infarct area(%)of each group.Values are expressed as meanÆSD,n=10per group, *P<0.05,**P<0.01versus Control.Stabilizing blood pressure and enhancing arterial baroreflex func-tion may become new strategies in prevention of stroke[20–22].A variety of chemicals,such as clonidine,moxonidine,folic acid,mecobalamin[23],and gastrodin[24],could enhance arte-rial baroreflex function in rats.Previous studies also found ketans-erin,a selective5-HT2A receptor antagonist,could reduce the incidence of fetal stroke in SHR-SP through restoring the impaired BRS in SHR-SP[20].Another report showed that SAD aggravated damage caused by MCAO and that acetylcholine-alpha7nAchR participates in the protection of arterial baroreflex against ische-mic stroke[25].In the present study,BRS was enhanced by levamlodipine alone and its combination with bisoprolol in SHR-SP.In SAD rats,SBPV was significantly decreased in rats receiving the combination treatment,but not by rather drug alone.The combination of levamlodipine and bisoprolol has better effects on stabilizing SBP and enhancing BRS than either drug alone.Con-sistent with these data,the lifespan of SHR-SP was significantly prolonged by the combination treatment with levamlodipine and bisoprolol.In the chronic experiments,we did not measure SBP, HP,SBPV,and BRS to avoid impact on survival.Nevertheless,this represents a limitation in the present study.In acute experiments,single treatment with both agents mark-edly reduced the infarct area in SD rats both with and without SAD.In SAD rats,the infarct area was also decreased by bisoprolol alone,which needs further investigation.Taken together,these results suggest that the combination of levamlodipine and bisoprolol could prevent stroke in rats by decreasing and stabilizing blood pressure as well as enhancing BRS.Conflict of InterestThe authors declare no conflict of interest.References1.Donnan GA,Fisher M,Macleod M,Davis SM.Stroke.Lancet2008;371:1612–1623.2.Gorelick PB.New horizons for stroke prevention:PROGRESS and ncet Neurol2002;1:149–156.3.Chobanian AV,Bakris GL,Black HR,et al.Theseventh report of the joint national committee onprevention,detection,evaluation,and treatment ofhigh blood pressure:the JNC7report.JAMA2003;289:2560–2572.4.Cruickshank JM.New guidelines on ncet2006;368:641.5.Yang YL,Yu LT,Wu ZT,et al.Synergic effects oflevamlodipine and bisoprolol on blood pressure reduction and organ protection in spontaneously hypertensive rats.CNS Neurosci Ther2012;18:471–474.6.Su DF.Treatment of hypertension based on measurementof blood pressure variability:lessons from animal studies.Curr Opin Cardiol2006;21:486–491.7.Miao CY,Xie HH,Zhan LS,Su DF.Blood pressurevariability is more important than blood pressure level in determination of end-organ damage in rats.J Hypertens2006;24:1125–1135.8.Yang C,Zhang X,Song SW,Yu JG,Cai GJ.Cerebralartery remodeling in stroke-prone spontaneouslyhypertensive S Neurosci Ther2011;17:785–786. 9.Su DF,Xu LP,Miao CY,et al.Two useful methods forevaluating antihypertensive drugs in conscious freelymoving rats.Acta Pharmacol Sin2004;25:148–151.10.XW G,HH X,J W,FM S,DF S.Arterial baroreflex is notinvolved in salt preference in rats.Clin Exp PharmacolPhysiol2006;33:5.11.Krieger EM.Neurogenic hypertension in the rat.Circ Res1964;15:511–521.12.Miao CY,Xie HH,Wang JJ,Su DF.Candesartan inhibitssinoaortic denervation-induced cardiovascularhypertrophy in rats.Acta Pharmacol Sin2002;23:713–720.13.Belayev L,Alonso OF,Busto R,Zhao W,Ginsberg MD.Middle cerebral artery occlusion in the rat byintraluminal suture.Neurological and pathologicalevaluation of an improved model.Stroke1996;27:1616–1622.14.Zhao H,Mayhan WG,Sun H.A modified suturetechnique produces consistent cerebral infarction in rats.Brain Res2008;1246:158–166.15.Uluc K,Miranpuri A,Kujoth GC,Akture E,Baskaya MK.Focal cerebral ischemia model by endovascular sutureocclusion of the middle cerebral artery in the rat.J VisExp2011;48:1978.16.Weir MR.The rationale for combination versus single-entity therapy in hypertension.Am J Hypertens1998;11:163S–169S.17.Robinson TG,Dawson SL,Eames PJ,Panerai RB,PotterJF.Cardiac baroreceptor sensitivity predicts long-termoutcome after acute ischemic stroke.Stroke2003;34:705–712.18.Yu JG,Zhou RR,Cai GJ.From hypertension to stroke:mechanisms and potential prevention SNeurosci Ther2011;17:577–584.19.Xie HH,Shen FM,Miao CY,Su DF.Blood pressure,baroreflex sensitivity,and end organ damage in hybridoffspring of spontaneously hypertensive rats and Sprague-Dawley rats.Acta Pharmacol Sin2005;26:1049–1056.20.Liu AJ,Ma XJ,Shen FM,et al.Arterial baroreflex:anovel target for preventing stroke in rat hypertension.Stroke2007;38:1916–1923.21.Song SW,Liu AJ,Bai C,et al.Blood pressure reductioncombining baroreflex restoration for stroke prevention inhypertension in rats.Front Pharmacol2010;1:6.22.Liu AJ,Guo JM,Xia W,Su DF.New strategies for theprevention of stroke.Clin Exp Pharmacol Physiol2010;37:265–271.23.Ma XJ,Shen FM,Liu AJ,et al.Clonidine,moxonidine,folic acid,and mecobalamin improve baroreflex functionin stroke-prone,spontaneously hypertensive rats.ActaPharmacol Sin2007;28:1550–1558.24.Liu W,Su BL,Wang ZS,et al.Gastrodin improvedbaroreflex sensitivity and increased gamma-amino butyricacid content in brains without decreasing blood pressurein spontaneously hypertensive S Neurosci Ther2012;18:873–875.25.Liu AJ,Zang P,Guo JM,et al.Involvement ofacetylcholine-alpha7nAChR in the protective effects ofarterial baroreflex against ischemic S NeurosciTher2012;18:918–926.。

相关文档
最新文档